Article
HBV genotypes and drug resistance mutations in antiretroviral treatment-naive and treatment-experienced HBV-HIV-coinfected patients.
Antiviral therapy - 1 Jan 2017
Archampong Timothy Na, Boyce Ceejay L, Lartey Margaret, Sagoe Kwamena W, Obo-Akwa Adjoa, Kenu Ernest, Blackard Jason T, Kwara Awewura
Abstract excerpt
BACKGROUND: The presence of HBV resistance mutations upon initiation or during antiretroviral therapy (ART) in HIV-coinfected patients is an important determinant of treatment response. The main objective of the study was to determine the prevalence of HBV resistance mutations in antiretroviral treatment-naive and treatment-experienced HBV-HIV-coinfected Ghanaian patients with detectable HBV viraemia. METHODS:...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.